Skip Navigation

Profile

Joseph Yeboah, M.B.Ch.B.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

72 Ratings
5 Comments
 

Joseph Yeboah, M.B.Ch.B.

Associate Professor,
Cardiovascular Sciences Ctr

Clinical Interests

Cardiac Imaging, Preventive Cardiology, Cardiac Magnetic Resonance Imaging, Nuclear Cardiology, Critical Care, Cardiology (clinical), Echocardiography

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-7015

Insurance Accepted »

Education & Training

  • B.S., University Ghana Medical School-Ghana, 1996
  • M.D., University Ghana Medical School-Ghana, 2000
  • M.S., WFU School of Medicine, 2007
  • Internship, Pediatric Surgery, Korle-Bu Teaching Hos, 2001
  • Internship, Internal Medicine, Korle-Bu Teaching Hos, 2002
  • Internship, Internal Medicine, Hosp Of St Raphael, 2003
  • Residency, Internal Medicine, Hosp Of St Raphael, 2005
  • Fellowship, Cardiology, WFU School of Medicine, 2007
  • Fellowship, Critical Care Medicine, WFU School of Medicine, 2008
  • Fellowship, Internal Medicine, University of Virginia School, 2011

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Critical Care Medicine

Memberships

  • American College of Cardiology
  • Am Heart Association

NPI Number

  • 1134241474
Joseph Yeboah, M.B.Ch.B.

Doctor Rating

4.6 out of 5

72 Ratings
5 Comments
 

Joseph Yeboah, M.B.Ch.B.

Associate Professor, Cardiology
Cardiovascular Sciences Ctr
Epidemiology & Prevention

Research Interests

Coronary Artery Disease; Atherosclerosis; Cardiovascular Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Brachial Artery
More »

Contact Information

Request An Appointment

Academic: 716 | Department: 336-716-7015

Recent Publications

Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus. Gomadam P, Shah A, Qureshi W, Yeboah PN [sic] Yeboah PK, Freedman BI, Bowden D, Soliman EZ, Yeboah J.. J Hypertens. 2018;36(1):85-92.

Relation of coronary artery calcium and extra-coronary aortic calcium to incident hypertension (from the Multi-Ethnic Study of Atherosclerosis). Aladin AI, Al Rifai M, Rasool SH, Dardari Z, Yeboah J, Nasir K, Budoff MJ, Psaty BM, Blumenthal RS, Blaha MJ, McEvoy JW.. Am J Cardiol. 2018;121(2):210-216.

Revised Framingham Stroke Risk Score, nontraditional risk markers, and incident stroke in a multiethnic cohort. Flueckiger P, Longstreth W, Herrington D, Yeboah J.. Stroke. 2018;49(2):363-369.

Road to the American Heart Association 2020 Impact Goals: the metric for monitoring progress [editorial]. Yeboah J.. Circ Cardiovasc Imaging. 2018;11(1):e007385.

Heart rate is an independent predictor of all-cause mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Prasada S, Oswalt C, Yeboah P, Saylor G, Bowden D, Yeboah J.. World J Diabetes. 2018;9(1):33-39.

Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). Flueckiger P, Qureshi W, Michos ED, Blaha M, Burke G, Sandfort V, Herrington D, Yeboah J.. Clin Cardiol. 2017;40(3):163-169.

Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy. McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, Budoff MJ, Goff DC, Psaty BM, Post WS, Nasir K, Blumenthal RS, Blaha MJ.. Circulation. 2017;135(2):153-165.

Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: the Multi-Ethnic Study of Atherosclerosis (MESA). Kim J, Budoff MJ, Nasir K, Wong ND, Yeboah J, Al-Mallah MH, Shea S, Dardari ZA, Blumenthal RS, Blaha MJ, Cainzos-Achirica M.. Atherosclerosis. 2017;257():1-8.

Coronary artery calcium scores for atherosclerotic cardiovascular disease risk stratification in smokers: MESA [abstract]. Leigh J, McEvoy J, Sandfort V, Qureshi W, Carr J, Oelsner EC, Budoff M, Herrington D, Yeboah J.. J Am Coll Cardiol. 2017;69(11 Suppl):1557.

Blood pressure indices and cardiovascular mortality in diabetics and non diabetics [abstract]. Gomadam P, Qureshi W, Shah A, Freedman B, Bowden DW, Soliman E, Yeboah J.. J Am Coll Cardiol. 2017;69(11 Suppl):1849.

Diet, height, and health [editorial]. Yeboah J.. Am J Clin Nutr. 2017;106(2):443-444.

Effect of intensive blood-pressure treatment on patient-reported outcomes. Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J, Rocco M,.. N Engl J Med. 2017;377(8):733-744.

The relationship of low-density lipoprotein (LDL) particle number (LDL-P) and LDL particle size and incident stroke events: the Multi-Ethnic Study of Atherosclerosis [abstract]. Kim YJ, Fan W, Budoff MJ, Mora S, Sacco RL Tracy R, Yeboah J, Wong ND.. Stroke. 2017;48(Suppl 1):AWP219.

Association of 10-year change in cardiovascular risk factors with progression of pericardial adipose tissue: the Cardia study [abstract]. Benes L, Terry J, Carr J, Jacobs D, Goff D, Yeboah J, Alman AC, Rana J, Chan C, Liu K, Polonsky T.. J Am Coll Cardiol. 2017;69(11 Suppl):1677.

N-terminal pro B-type natriuretic peptide, race, and flow-mediated dilation: Multi-Ethnic Study of Atherosclerosis [abstract]. Yang S, Huang S, Yeboah J, Daniels L, Lima J, Beckman J, Carr J, Wang T, Gupta D.. J Am Coll Cardiol. 2017;69(11 Suppl):2029.

Coronary artery calcium and estimated cardiovascular disease risk in five racial/ethnic groups living in the US: the mediators of atherosclerosis in South Asians living in America (MASALA) study and the Multi-Ethnic Study of Atherosclerosis. Patel J, Dardari Z, Cainzos-Achirica M, Joshi P, Kandula N, Budoff M, Yeboah J, Szklo M, Guallar E, Blumenthal R, Kanaya A, Blaha M.. J Am Coll Cardiol. 2017;69(11 Suppl):1555.

Adult height, prevalent coronary artery calcium score, and incident cardiovascular disease outcomes in a multi-ethnic cohort. Yeboah J, Blaha MJ, Michos ED, Qureshi W, Miedema M, Flueckiger P, Rodriguez CJ, Szklo M, Bertoni AG.. Am J Epidemiol. 2017;186(8):935-943.

Usefulness of coronary artery calcium to predict heart failure with preserved ejection fraction in men versus women (from the Multi-Ethnic Study of Atherosclerosis). Sharma K, Al Rifai M, Ahmed HM, Dardari Z, Silverman MG, Yeboah J, Nasir K, Sklo M, Yancy C, Russell SD, Blumenthal RS, Blaha MJ.. Am J Cardiol. 2017;120(10):1847-1853.

Thoracic extra-coronary calcification for the prediction of stroke: the Multi-Ethnic Study of Atherosclerosis. Kianoush S, Al Rifai M, Cainzos-Achirica M, Al-Mallah MH, Tison GH, Yeboah J, Miedema MD, Allison MA, Wong ND, DeFilippis AP, Longstreth W, Nasir K, Budoff MJ, Matsushita K, Blaha MJ.. Atherosclerosis. 2017;267():61-67.

Association between mean systolic blood pressure and cardiovascular outcomes in diabetes mellitus: ACCORD trial. Yeboah J, Byington B, Bertoni A.. J Hum Hypertens. 2017;():.

Diagnostic value of coronary artery calcium score for cardiovascular disease in African Americans: the Jackson Heart Study. Sung JH, Yeboah J, Lee JE, Smith CL, Terry JG, Sims M, Samdarshi T, Musani S, Fox E, Ge Y, Wilson JG, Taylor HA, Carr JJ.. Br J Med Med Res. 2016;11(2):.

Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.. J Am Coll Cardiol. 2016;67(2):139-147.

Prognosis of low normal left ventricular ejection fraction in an asymptomatic population-based adult cohort: the Multiethnic Study of Atherosclerosis. Yeboah J, Rodriguez CJ, Qureshi W, Liu S, Carr JJ, Lima JA, Hundley WG, Herrington DM.. J Card Fail. 2016;22(10):763-768.

Impact of replacing the Pooled Cohort Equation with other cardiovascular disease risk scores on atherosclerotic cardiovascular disease risk assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Qureshi WT, Michos ED, Flueckiger P, Blaha M, Sandfort V, Herrington DM, Burke G, Yeboah J.. Am J Cardiol. 2016;118(5):691-696.

Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT Jr, Yeboah J.. J Am Soc Hypertens. 2016;10(11):847-856.

Providing evidence for subclinical CVD in risk assessment. Blaha MJ, Yeboah J, Al Rifai M, Liu K, Kronmal R, Greenland P.. Glob Heart. 2016;11(3):275-285.

Pedal edema as an indicator of early heart failure in the community: prevalence and associations with cardiac structure/function and natriuretic peptides (MESA [Multiethnic Study of Atherosclerosis]). Yeboah J, Bertoni A, Qureshi W, Aggarwal S, Lima JA, Kawel-Boehm N, Bluemke DA, Shah SJ.. Circ Heart Fail. 2016;9(12):e003415.

Role of extra-coronary calcification on cardiac-gated computed tomography in the prediction of stroke: a Multi-Ethnic Study of Atherosclerosis [abstract]. Kianoush S, Al-Rifai M, Cainzos-Achirica M, Al-Mallah M, Tison GH, Yeboah J, Miedema MD, Allison MA, Wong ND, DeFilippis AP, Nasir K, Longstreth W, Budoff MJ, Matsushita K, Blaha MJ.. Circulation. 2016;134(Suppl 1):A16608.

Postoperative blood urea nitrogen is associated with stroke in cardiac surgical patients. Arnan MK, Hsieh TC, Yeboah J, Bertoni AG, Burke GL, Bahrainwala Z, Grega MA, Baumgartner WA, Gottesman RF.. Ann Thorac Surg. 2015;99(4):1314-1320.

Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Chotenimitkhun R, D'Agostino R Jr, Lawrence JA, Hamilton CA, Jordan JH, Vasu S, Lash TL, Yeboah J, Herrington DM, Hundley WG.. Can J Cardiol. 2015;31(3):302-307.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.. Am Heart J. 2015;169(3):387-395.e3.

Transthoracic echocardiography. Yeboah J, Upadhya B. In: Lefebvre C, O'Neill JC, Cline DM, eds. The atlas of cardiovascular emergencies. New York: McGraw-Hill Education;2015: 43-45.

Association of sleep apnea and snoring with incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis. Lin GM, Colangelo LA, Lloyd-Jones DM, Redline S, Yeboah J, Heckbert SR, Nazarian S, Alonso A, Bluemke DA, Punjabi NM, Szklo M, Liu K.. Am J Epidemiol. 2015;182(1):49-57.

Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines. Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.. Circulation. 2015;132(10):916-922.

Coronary artery calcium as a predictor of incident heart failure with preserved ejection fraction: results from the Multi-Ethnic Study of Atherosclerosis (MESA) [abstract]. Sharma K, Ahmed H, Dardari Z, Silverman MG, Yancy CW, Szklo M, Yeboah J, Russell SD, Blumenthal RS, Blaha MJ.. J Card Fail. 2015;21(8 Suppl):S110.

Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention [commentary]. Yeboah J.. Evid Based Med. 2015;20(6):230.

Associations of body composition measures and C2, a marker for small artery elasticity: the MESA. Forbang NI, Allison MA, Ix JH, Criqui MH, Vaidya D, Yeboah J, Duprez DA, Jacobs DR Jr.. Obesity (Silver Spring). 2015;23(11):2294-2298.

Risk stratification for primary prevention of coronary artery disease: roles of C-reactive protein and coronary artery calcium. Qureshi WT, Rana JS, Yeboah J, Bin Nasir U, Al-Mallah MH.. Curr Cardiol Rep. 2015;17(12):110.

Coronary artery calcium progression and atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. O'Neal WT, Efird JT, Qureshi WT, Yeboah J, Alonso A, Heckbert SR, Nazarian S, Soliman EZ.. Circ Cardiovasc Imaging. 2015;8(12):e003786.

Cancer and its association with the development of coronary artery calcification: an assessment from the Multi-Ethnic Study of Atherosclerosis. Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG.. J Am Heart Assoc. 2015;4(11):e002533.

Class I indications for statin therapy in primary prevention by three cholesterol guidelines and risk of incident cardiovascular outcomes: Multi-ethnic Study of Atherosclerosis (MESA) [abstract]. Flueckiger P, Qureshi W, Blaha M, Burke G, Sandfort V, Michos ED, Herrington D, Yeboah J.. Circulation. 2015;132(Suppl 3):A12490.

The impact of replacing the pooled cohort equation with other CVD risk scores on atherosclerosis cardiovascular disease risk assessment: MESA [abstract]. Qureshi W, Flueckiger P, Blaha M, Michos ED, Sandfort V, Herrington DM, Burke G, Yeboah J.. Circulation. 2015;132(Suppl 3):A10128.

Class I indication for statin therapy in primary prevention by three cholesterol guidelines and prevalence of coronary artery calcium in asymptomatic adults: Multi-ethnic Study of Atherosclerosis (MESA) [abstract]. Flueckiger P, Qureshi W, Blaha M, Burke G, Sandfort V, Michos ED, Herrington D, Yeboah J.. Circulation. 2015;132(Suppl 3):A12119.

Intermediate end point cardiovascular clinical trials: an excellent idea based on an obsolete paradigm. Yeboah J, Herrington DM.. Expert Rev Cardiovasc Ther. 2014;12(2):161-165.

A functionally significant polymorphism in ID3 is associated with human coronary pathology. Manichaikul A, Rich SS, Perry H, Yeboah J, Law M, Davis M, Parker M, Ragosta M, Connelly JJ, McNamara CA, Taylor AM.. PLoS One. 2014;9(3):e90222.

Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, Carr JJ, Freedman BI, Herrington DM, Bowden DW.. Diabetes Care. 2014;37(5):1454-1461.

Mediation of cardiovascular risk factor effects through subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Yeboah J, Delaney JA, Nance R, McClelland RL, Polak JF, Sibley CT, Bertoni A, Burke GL, Carr JJ, Herrington DM.. Arterioscler Thromb Vasc Biol. 2014;34(8):1778-1783.

Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ.. Eur J Prev Cardiol. 2014;21(10):1233-1241.

Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study. Ahmed FS, Jiang XC, Schwartz JE, Hoffman EA, Yeboah J, Shea S, Burkart KM, Barr RG.. Biomarkers. 2014;19(3):207-213.

Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jockel KH, Burke GL, Wong ND, Lehmann N, Herrington DM, Mohlenkamp S, Greenland P.. Atherosclerosis. 2014;236(2):411-417.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Cardiology

Clinical Interests

Cardiac Imaging, Preventive Cardiology, Cardiac Magnetic Resonance Imaging, Nuclear Cardiology, Critical Care, Cardiology (clinical), Echocardiography
Joseph Yeboah, M.B.Ch.B.

Joseph Yeboah, M.B.Ch.B.

Associate Professor, Cardiology
Cardiovascular Sciences Ctr
Epidemiology & Prevention

Request An Appointment

Doctor Rating

4.6 out of 5

Joseph Yeboah, M.B.Ch.B.72 Ratings
5 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.7
Time CP spent with patient
4.6
Wait time at clinic
4.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

12/14/2017

Dr. Yaboia has been great all the years that he has been my cardiologist.

10/27/2017

I love my doctor. He has always been informative and helpful. I feel he CARES.

8/5/2017

explains well

6/8/2017

1. *Joseph Yeboah MD.

5/3/2017

Dr. was serious with good and caring personality.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.